baber/WOPTO huggingface dataset:
Patent AU-2002307228-B2 (AU)
Title: Radial sealed air brake chamber
Inventor: PISONI STEFFEN
IPC: F16D65/14
Filed: 2002-04-09
Granted: 2005-07-14
Abstract: A service brake actuator having a housing base having a center portion and a housing cover having a center portion is provided. The center portion of the housing base and the center portion of the housing cover telescopingly fit together in an assembled position and define an annular space therebetween. A diaphragm having a thickness greater than the thickness of the annular space between the center portion of the housing base and the center portion of the housing cover is held in the annular space by radial forces generated by compression of the diaphragm in the annular space. It should be understood that the magnitude of the radial forces holding the diaphragm in the annular space is variable depending on the thickness of the annular space.
Patent AU-2002310976-B2 (AU)
Title: Tert. alkylphenoxy substituted polycyclic compounds
Inventor: KRIEGER MATTHIAS
IPC: C09D11/02
Filed: 2002-03-20
Granted: 2007-11-01
Abstract: Tert-alkylphenoxy-substituted polycyclic compounds of the general formula I where P is a conjugated polycyclic radical which is stable to bases and nucleophiles, optionally bears aryl substituents and contains no group from the group consisting of -CO-NH-CO-, -COOH and -CO-O-CO-; R is C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl, whose carbon chain may be interrupted by one or more groups selected from the group consisting of -O-, -S-, -NR<SUP>1</SUP>-, -CO- and/or -SO<SUB>2</SUB>- and which may be monosubstituted or polysubstituted by C<SUB>1</SUB>-C<SUB>6</SUB>-alkoxy or by a 5- to 7-membered heterocyclic radical which is attached via a nitrogen atom and may contain further heteroatoms and be aromatic; C<SUB>5</SUB>-C<SUB>8</SUB>-cycloalkyl whose carbon chain may be interrupted by one or more groups selected from the group consisting of -O-, -S-, -NR<SUP>1</SUP>-, -CO- and/or -SO<SUB>2</SUB>- and which may be monosubstituted or polysubstituted by C<SUB>1</SUB>-C<SUB>6</SUB>-alkyl; R<SUP>1 </SUP>is hydrogen or C<SUB>1</SUB>-C<SUB>6</SUB>-alkyl; Hal is chlorine and/or bromine; m is from 0 to 15; n is from 1 to 16, subject to the proviso that the sum m+n is <=16, are prepared and used.
Patent AU-2002314131-B2 (AU)
Title: Method and device for obtaining fatty acid esters from native oils and fats by means of the enzymatic separation thereof
Inventor: BRUNNER KARLHEINZ
IPC: C12M1/00
Filed: 2002-06-04
Granted: 2007-11-01
Abstract: Process (I) for the enzymatic hydrolysis of oils and fats to produce fatty acids and glycerol by contacting a mixture of the oil or fat and water with lipase biocatalyst comprises: (a) carrying out the hydrolysis reaction until the reaction rate falls below a preset value; (b) separating the aqueous glycerol phase; (c) separating the fatty acids from the organic phase; and (d) recycling the rest of the organic phase. Independent claims are also included for: (1) a process (II) for the enzymatic hydrolysis of oils and fats to produce fatty acids and glycerol by contacting a mixture of the oil or fat and water with a lipase biocatalyst, comprising: (a) separating the hydrolysis reaction mixture into an aqueous glycerol phase and an organic phase in a self-discharging separator operated so that a lipase-enriched layer collects between the aqueous and organic phases in the plate stack of the separator; (b) emptying the separator at preset times; and (c) recycling the discharged contents of the separator drum; and (2) a process (III) for the enzymatic hydrolysis of oils and fats to produce fatty acids and glycerol by contacting a mixture of the oil or fat and water with a lipase biocatalyst, comprising carrying out the hydrolysis discontinuously in multiple parallel reactors operating in a loop system, with pumped recirculation of the reactor contents so that one reactor is being filled with oil or fat while another is in hydrolysis service, and another is being emptied into a separator which separated the aqueous glycerol phase from the organic phase before the fatty acids are separated from the organic phase.
Patent AU-2002351591-B2 (AU)
Title: Handheld electronic device with keyboard
Inventor: GRIFFIN JASON T
IPC: G06F3/023
Filed: 2002-12-17
Granted: 2006-07-20
Abstract: A keyboard for a handheld electronic device comprises ten keys arranged in four rows in a DTMF keypad format. Three of the keys respectively bearing numerals 1, 2 and 3 arranged in a first row, three of the keys respectively bearing numerals 4, 5 and 6 arranged in a second row, three of the keys respectively bearing numerals 7, 8 and 9 arranged in a third row, and a tenth key bearing a 0 located in a fourth row. The keys of the first second and third rows also bear letter characters which, either alone or in conjunction with additional letter character-bearing keys in the rows, are positioned relative to the letter characters on adjacent keys so as to form a QWERTY or Dvorak layout.
Patent AU-2003247788-B2 (AU)
Title: Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes
Inventor: HETZEL SUSAN R
IPC: C12Q1/68
Filed: 2003-07-02
Granted: 2007-04-19
Abstract: This invention provides polyanionic polymer conjugates containing non-nucleotide polyanionic polymers that are useful in detecting target analytes such as proteins or small molecules. The invention also provides nanoparticles bound to polyanionic polymer conjugates and methods of preparation and use thereof. The polyanionic polymer conjugates have the formula: <?in-line-formulae description="In-line Formulae" end="lead"?>L-O-[PO<SUB>2</SUB>-O-Z-O]<SUB>n</SUB>-PO<SUB>2</SUB>-O-X<?in-line-formulae description="In-line Formulae" end="tail"?> wherein n ranges from 1 to 200; L represents a moiety comprising a functional group for attaching the polyanion polymer to the nanoparticle surface; Z represents a bridging group, and X represents Q, X' or -Q-X', wherein Q represents a functional group for attaching a recognition probe to the polyanion polymer, and X' represents a recognition probe.
Patent AU-2003295776-B2 (AU)
Title: 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
Inventor: RENHOWE PAUL A
IPC: C07D401/12
Filed: 2003-11-21
Granted: 2011-05-12
Abstract: Compounds having formula I are provided where the variables have the values described herein.   
Pharmaceutical formulations include the compounds or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier and combinations with other agents. These compounds are phosphotidylinositol 3-kinase (PI3K) inhibitors.
Patent AU-2003301414-B2 (AU)
Title: Novel compounds with antibacterial activity
Inventor: HUSCHWERLEN CHRISTIAN
IPC: C07D401/12
Filed: 2003-10-09
Granted: 2010-05-13
Abstract: 4-substituted quinoline derivatives (I), their salts, solvates, hydrates and formulations are new. 4-substituted quinoline derivatives of formula (I), their salts, solvates, hydrates and formulations are new. [Image] A : oxygen, sulfur, nitrogen, 1-4C (hetero)alkylene or 2-4C alkenylene or alkynylene; X 1-X 5nitrogen or CR 2>; R 1>hydrogen, hydroxy or (hetero)alkoxy; R 2>hydrogen, halo, hydroxy, (hetero)alkyl, alkenyl or alkynyl; R 3>a group of formula (i)-(viii); R 4>hydroxy, 1-6C alkyl or 1-8C heteroalkyl; R 5>(hetero)alkyl, alkenyl, alkynyl, (hetero)aryl, (alkyl)cycloalkyl, heteroalkylcycloalkyl, heterocycloalkyl, aralkyl or heteroaralkyl; n : 0-3; and m : 0 or 2. [Image] ACTIVITY : Antibacterial. 2-((3RS)-{[(2,3-dihydrobenzo[1,4]dioxon-6-ylmethyl)amino]methyl} piperidin-1-yl)-(1RS)-(6-methoxyquinolin-4-yl)ethanol (Ia) had MIC below 0.5 Microg/ml against at least one of the strains Staphylococcus aureusATCC 29213 or I6; E. faecalisATCC 29212; E. faeciumvanA E25-1; Haemophilus influenzae11; Escherichia coliATCC 25922; M. catarrhalisand Streptococcus pneumoniaeATCC 49619. MECHANISM OF ACTION : None given.
Patent AU-2004252067-B2 (AU)
Title: CD20-specific antibodies and methods of employing same
Inventor: TEDDER THOMAS F
IPC: C12N5/20
Filed: 2004-05-07
Granted: 2012-04-12
Abstract: The present invention provides monoclonal antibodies and antigen-binding fragments thereof that specifically bind to CD20, as well as pharmaceutical compositions comprising the same. The invention further provides methods of using the monoclonal antibodies, antigen-binding fragments, and pharmaceutical compositions, for example, in methods of depleting B cells or in treating B cell disorders. Also provided are cells, nucleic acids and methods for producing the monoclonal antibodies.
Patent AU-2004313657-B2 (AU)
Title: Novel medicine pack
Inventor: KLATT ANDREAS
IPC: B65D75/32
Filed: 2004-10-22
Granted: 2010-09-16
Abstract: Medicine pack comprises blister units (1), each having a protective case (6), with a blister strip (4). The blister strip is fixedly connected to the protective case, which is capable of being unfolded or opened out. An outer package is provided for receiving the blister units. It is configured in a way that the pack content can be fixed in the inside of the outer package.
Patent AU-2005202273-B2 (AU)
Title: Apparatus and methods for occluding a hollow anatomical structure
Inventor: BERKY CRAIG B
IPC: A61B17/10
Filed: 2005-05-25
Granted: 2011-09-15
Abstract: APPARATUS AND METHODS FOR OCCLUDING A HOLLOW ANATOMICAL STRUCTURE Abstract of the Disclosure A device (10) for occluding a hollow anatomical structure includes 5 a clamp (12) having at least first and second clamping portions (12a, 12B) adapted to be placed on opposite sides of the anatomical structure. At least one of the first and second clamping portions (1 2a, 12b) is movable toward the other from an open position to a clamping or closed position to occlude the anatomical structure. The clamp (12) has an annular shape configured to 10 surround the hollow anatomical structure in the open position and a flattened shape in the clamping position configured to occlude the hollow interior of the anatomical structure. The clamp (12) is preferably covered with fabric to promote tissue ingrowth. A clamp delivery and actuation device (20) is provided for allowing the clamp (12) to be applied in either an open surgical 15 procedure or a minimally invasive procedure. /r it I 2 _
Patent AU-2005274384-B2 (AU)
Title: Combinations for the treatment of diseases involving cell proliferation
Inventor: GERD MUNZERT
IPC: A61K31/519
Filed: 2005-08-09
Granted: 2011-06-23
Abstract: The present invention relates to a pharmaceutical composition for the treatment of diseases which involve cell proliferation. The invention also relates to a method for the treatment of said diseases, comprising co-administration of a compound 1 of Formula (I) wherein the groups L, R1, R2, R3, R4 and R5 have the meanings given in the claims and specification, optionally in form of its tautomers, racemates, enantiomers, diastereomers and the mixtures thereof and optionally in form of the pharmacologically acceptable acid addition salts, solvates, hydrates, polymorphs, physiologically functional derivatives or prodrugs thereof, and of an effective amount of an active compound 2 and/or co-treatment with radiation therapy, in a ratio which provides an additive and synergistic effect, and to the combined use of a compound 1 of Formula (I) and of an effective amount of an active compound 2 and/or radiotherapy for the manufacture of corresponding pharmaceutical combination preparations.
Patent AU-2005296001-B2 (AU)
Title: Syringe devices and methods for mixing and administering medication
Inventor: MICHAELSEN RUSSELL A
IPC: A61M5/20
Filed: 2005-10-07
Granted: 2012-01-19
Abstract: The invention includes a device having a chamber within a syringe. A fluid passageway extends through a syringe piston. A valve is associated with the passageway controlling fluid passage through the piston. The invention includes a piercing structure having a head segment and a body portion, with a channel through the body portion and through at least one surface of the head without passing through the tip. In another aspect the invention encompasses a method of preparing an agent for administration to an individual. A first component is provided within a syringe and a second component is provided within a vial. A closed valve is associated with a fluid passageway between the vial and the syringe barrel through a piston. Valve repositioning allows fluid passage and sliding of the piston joins the first and second components. Repeated sliding of the piston mixes the components to produce the medication agent.
Patent AU-2005311530-B2 (AU)
Title: Particle based binding assay
Inventor: MIRA MURTOVUORI
IPC: G01N33/569
Filed: 2005-11-23
Granted: 2011-12-15
Abstract: The present invention provides a method for detecting the presence or amount of an analyte in a sample, said method comprising: a porous surface to which particles having attached thereto a binding substance, analyte and binding substance coated label particles are added. If said analyte is present in the sample an immuno- or chemical reaction occurs in the liquid phase. The separation of bound complex from unbound material is achieved by using said surface where the separation occurs mainly two dimensionally on the surface of the porous surface (e.g. grid). Interestingly, the disclosed surface enables a separation where said complexes are distributed two dimensionally on the porous surface (e.g. grid), whereas unbound materials are distributed three dimensionally. Accordingly, said surface enables both a two and a three dimensional separation.
Patent AU-2006239999-B2 (AU)
Title: In situ conversion process systems utilizing wellbores in at least two regions of a formation
Inventor: HSU CHIA-FU
IPC: E21B43/24
Filed: 2006-04-21
Granted: 2010-06-17
Abstract: A heating system for a subsurface formation is described. The heating system includes a first heater, a second heater, and a third heater placed in an opening in the subsurface formation. Each heater includes: an electrical conductor; an insulation layer at least partially surrounding the electrical conductor; and an electrically conductive sheath at least partially surrounding the insulation layer. The electrical conductor is electrically coupled to the sheath at a lower end portion of the heater. The lower end portion is the portion of the heater distal from a surface of the opening. The first heater, the second heater, and the third heater are electrically coupled at the lower end portions of the heaters. The first heater, the second heater, and the third heater are configured to be electrically coupled in a three-phase wye configuration.
Patent AU-2006265083-B2 (AU)
Title: Improved phosphorus removal system and process
Inventor: ZUBACK JOSEPH E
IPC: C02F1/52
Filed: 2006-07-05
Granted: 2011-09-22
Abstract: A phosphorus removal system is operable to remove phosphorus from an influent. The system includes a first section receiving the influent and discharging a first flow. A first coagulant inlet is positioned upstream of the first section and is in fluid communication with the influent to introduce a first coagulant selected to precipitate phosphorus. A second section receives the first flow and discharges a second flow, and a third section receives the second flow and discharges an effluent. A second coagulant inlet is positioned downstream of the first section and upstream of the third section to introduce a second coagulant selected to precipitate phosphorus.
Patent AU-2006265842-B2 (AU)
Title: Tubular solid oxide fuel cell current collector
Inventor: ARMSTRONG TIMOTHY R
IPC: H01M8/12
Filed: 2006-06-30
Granted: 2010-03-04
Abstract: An internal current collector for use inside a tubular solid oxide fuel cell (TSOFC) electrode comprises a tubular coil spring disposed concentrically within a TSOFC electrode and in firm uniform tangential electrical contact with the electrode inner surface. The current collector maximizes the contact area between the current collector and the electrode. The current collector is made of a metal that is electrically conductive and able to survive under the operational conditions of the fuel cell, i.e., the cathode in air, and the anode in fuel such as hydrogen, CO, CO2, H2O or H2S.
Patent AU-2006270348-B2 (AU)
Title: Method, system and computer program product for executing a marketing campaign
Inventor: MILLER REAGAN R
IPC: G06F17/30
Filed: 2006-07-07
Granted: 2011-09-29
Abstract: The present invention relates to a method system and a computer program to execute a marketing campaign through multiple communication mediums. Customers are contacted through emails, mails and mails for marketing products or services. The system executing the marketing campaign receives the customers' responses and classifies the customer responses accordingly. The system further generates a consolidated report for the marketing campaign based on the customers' responses.
Patent AU-2006287120-B2 (AU)
Title: Modified chaperonin 10
Inventor: NAYLOR DEAN JASON
IPC: C07K14/47
Filed: 2006-08-31
Granted: 2012-02-02
Abstract: The present invention relates to isolated Chaperonin 10 polypeptides possessing immunomodulatory activity, but lacking, or substantially lacking, protein folding activity.
Patent AU-2006303039-B2 (AU)
Title: Method of processing an image
Inventor: YURIY ALEXANDROV
IPC: G06T5/20
Filed: 2006-10-18
Granted: 2011-11-10
Abstract: A method of processing an input image produces an output image emphasising peak-like structures. The input image comprises input pixels and each input pixel has an intensity characteristic. The output image comprises corresponding output pixels and each output pixel has a value. The method comprises the step of calculating for an input pixel the second derivative of the intensity characteristic in two orthogonal directions, one of the directions being the direction of maximum curvature. The product of the two second derivatives is calculated and the value of the output pixel corresponding to the input pixel is determined in dependence on the product.
Patent AU-2006310690-B2 (AU)
Title: Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
Inventor: PAN YUANLONG
IPC: A23L33/00
Filed: 2006-11-02
Granted: 2012-05-31
Abstract: Edible compositions useful for weight management in male animals are disclosed. The compositions comprise one or more isoflavones or isoflavone metabolites and are particularly useful for reducing or preventing the accumulation of body fat. Also disclosed are methods useful for weight management in an animal utilizing compositions comprising one or more isoflavones. The compositions and methods are particularly useful for the reduction or prevention of body fat accumulation during periods of excess caloric intake, and preferably have a sparing effect on lean body mass.
Patent AU-2006330409-B2 (AU)
Title: Treatment of peripheral vascular disease using postpartum-derived cells
Inventor: KIHM ANTHONY J
IPC: A61K35/48
Filed: 2006-12-28
Granted: 2012-07-19
Abstract: Compositions and methods of using cells derived from postpartum tissue such as the umbilical cord and placenta, to stimulate and support angiogenesis, to improve blood flow, to regenerate, repair, and improve skeletal muscle damaged by a peripheral ischemic event, and to protect skeletal muscle from ischemic damage in peripheral vascular disease patients are disclosed.
Patent AU-2007209763-B2 (AU)
Title: An improved method of interpolation between a plurality of observed tensors
Inventor: HOLSTEIN HORST
IPC: G01V7/06
Filed: 2007-01-24
Granted: 2012-08-16
Abstract: A method of interpolation between a plurality of field gradient tensors including the steps of: accessing a plurality of field gradient data; formatting said plurality of field gradient data into 3-dimensional tensors of rank 2; determining a rotational matrix and a structural matrix for each tensor; interpolating said structural matrices; detecting errors in the raw data only apparent using the rotational component. interpolating said rotational matrices as quaternions on the surface of a unit 4-sphere; reconstructing said structural matrices and said rotational matrices to yield field gradient tensors at the interpolation points, wherein the interpolation is between two said field gradient tensors, the field gradient tensors being expressed as 3 x 3 matrices of values, each resolved into a rotational matrix and a structural matrix with three diagonal components.
Patent AU-2007249443-B2 (AU)
Title: Isothiazolidines useful in the treatment of ocular hypertensive conditions
Inventor: OLD DAVID W
IPC: C07D417/12
Filed: 2007-05-09
Granted: 2012-09-27
Abstract: Disclosed herein is a compound having a structure (I) or a pharmaceutically acceptable salt thereof, or a prodrug thereof. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
Patent AU-2007249635-B2 (AU)
Title: High throughput genome sequencing on DNA arrays
Inventor: DRMANAC RADOJE
IPC: C12Q1/68
Filed: 2007-02-26
Granted: 2012-05-31
Abstract: The present invention is directed to methods and compositions for acquiring nucleotide sequence information of target sequences using adaptors interspersed in target polynucleotides. The sequence information can be new. e.g. sequencing unknown nucleic acids, re-sequencing, or genotyping. The invention preferably includes methods for inserting a plurality of adaptors at spaced locations within a target polynucleotide or a fragment of a polynucleotide. Such adaptors may serve as platforms for interrogating adjacent sequences using various sequencing chemistries, such as those that identify nucleotides by primer extension, probe ligation, and the like. Encompassed in the invention are methods and compositions for the insertion of known adaptor sequences into target sequences, such that there is an interruption of contiguous target sequence with the adaptors. By sequencing both "upstream" and "downstream" of the adaptors, identification of entire target sequences may be accomplished.
Patent AU-2007257367-B2 (AU)
Title: Carton with article retaining feature
Inventor: GOMES JEAN-MANUEL
IPC: B65D5/72
Filed: 2007-05-16
Granted: 2011-03-31
Abstract: A carton includes a retaining structure that is arranged to retain articles within the carton when an end of the carton has been opened. The retaining structure includes an obstruction spaced from the opened end of the carton that abuts an article located at a dispenser opening of the carton.
Patent AU-2007258055-B2 (AU)
Title: Wirelessly controlling unmanned aircraft and accessing associated surveillance data
Inventor: WHEELER MATT
IPC: H04W4/40
Filed: 2007-05-17
Granted: 2013-09-26
Abstract: Controlling an unmanned aerial vehicle (UAV) may be accomplished by using a wireless device (e.g., cell phone) to send a control message to a receiver at the UAV via a wireless telecommunication network (e.g., an existing cellular network configured primarily for mobile telephone communication). In addition, the wireless device may be used to receive communications from a transmitter at the UAV, wherein the wireless device receives the communications from the transmitter via the wireless network. Examples of such communications include surveillance information and UAV monitoring information.
Patent AU-2007258731-B2 (AU)
Title: Oxime derivatives as inhibitors of macrophage migration inhibitory factor
Inventor: AL-ABED YOUSEF
IPC: A01N57/00
Filed: 2007-06-04
Granted: 2013-01-31
Abstract: Provided are compounds of formula (I) and other compounds. Also provided are pharmaceutical compositions comprising these compounds. Additionally, methods of inhibiting macrophage migration inhibitory factor (MIF) activity in a mammal are provided, as are methods of treating or preventing inflammation in a mammal, and methods of treating a mammal having sepsis, septicemia, and/or endotoxic shock.